STOCK TITAN

ICON plc to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, has announced upcoming presentations at two major healthcare investor conferences. Dr. Steve Cutler, CEO of ICON plc, is scheduled to present at:

  • The Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025, at 8:00 am ET
  • The Barclays 27th Annual Global Healthcare Conference on Thursday, March 13, 2025, at 8:30 am ET

Any updates to these events and live webcast links will be available in the Investor section of ICON's website under 'Events'.

ICON plc (NASDAQ: ICLR), una delle principali organizzazioni di ricerca clinica a livello mondiale, ha annunciato prossime presentazioni in due importanti conferenze per investitori nel settore sanitario. Dr. Steve Cutler, CEO di ICON plc, è programmato per presentare:

  • La Leerink Partners Global Healthcare Conference mercoledì 12 marzo 2025, alle 8:00 ET
  • La Barclays 27th Annual Global Healthcare Conference giovedì 13 marzo 2025, alle 8:30 ET

Eventuali aggiornamenti su questi eventi e i link per la diretta saranno disponibili nella sezione Investitori del sito web di ICON sotto 'Eventi'.

ICON plc (NASDAQ: ICLR), una organización líder mundial en investigación clínica, ha anunciado próximas presentaciones en dos importantes conferencias de inversores en el sector de la salud. Dr. Steve Cutler, CEO de ICON plc, está programado para presentar en:

  • La Leerink Partners Global Healthcare Conference el miércoles 12 de marzo de 2025, a las 8:00 am ET
  • La Barclays 27th Annual Global Healthcare Conference el jueves 13 de marzo de 2025, a las 8:30 am ET

Cualquier actualización sobre estos eventos y los enlaces para la transmisión en vivo estarán disponibles en la sección de Inversores del sitio web de ICON bajo 'Eventos'.

ICON plc (NASDAQ: ICLR), 세계적인 임상 연구 기관으로, 두 개의 주요 의료 투자자 회의에서의 발표를 발표했습니다. Steve Cutler 박사, ICON plc의 CEO는 다음과 같이 발표할 예정입니다:

  • Leerink Partners Global Healthcare Conference에서 2025년 3월 12일 수요일, 오전 8:00 ET
  • Barclays 제27회 연례 글로벌 헬스케어 회의에서 2025년 3월 13일 목요일, 오전 8:30 ET

이벤트에 대한 업데이트 및 생중계 링크는 ICON 웹사이트의 투자자 섹션 '이벤트'에서 확인할 수 있습니다.

ICON plc (NASDAQ: ICLR), une organisation de recherche clinique de premier plan dans le monde, a annoncé des présentations à venir lors de deux grandes conférences pour investisseurs dans le secteur de la santé. Dr. Steve Cutler, PDG d'ICON plc, est prévu pour présenter :

  • À la Leerink Partners Global Healthcare Conference le mercredi 12 mars 2025, à 8h00 ET
  • À la Barclays 27th Annual Global Healthcare Conference le jeudi 13 mars 2025, à 8h30 ET

Toutes les mises à jour concernant ces événements et les liens de diffusion en direct seront disponibles dans la section Investisseurs du site web d'ICON sous 'Événements'.

ICON plc (NASDAQ: ICLR), eine weltweit führende klinische Forschungsorganisation, hat bevorstehende Präsentationen auf zwei wichtigen Investorenkonferenzen im Gesundheitswesen angekündigt. Dr. Steve Cutler, CEO von ICON plc, wird präsentieren:

  • Auf der Leerink Partners Global Healthcare Conference am Mittwoch, den 12. März 2025, um 8:00 Uhr ET
  • Auf der Barclays 27th Annual Global Healthcare Conference am Donnerstag, den 13. März 2025, um 8:30 Uhr ET

Aktualisierungen zu diesen Veranstaltungen und Links zu den Live-Übertragungen sind im Investorenbereich der ICON-Website unter 'Veranstaltungen' verfügbar.

Positive
  • None.
Negative
  • None.

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025 at 8.00 am ET and at the Barclays 27th Annual Global Healthcare Conference on Thursday, March 13, 2025 at 8.30 am ET.

Any changes to these events and links to the live webcasts will be posted on the Investor section of our website under “Events”.

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,900 employees in 106 locations in 55 countries as at December 31, 2024. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-G

Contact: Kate Haven Vice President Investor Relations +1888 381 7923

Source: ICON plc

FAQ

When is ICON plc (ICLR) presenting at the Leerink Partners Conference in 2025?

ICON plc (ICLR) will present at the Leerink Partners Global Healthcare Conference on March 12, 2025, at 8:00 am ET.

Which investor conferences will ICON plc (ICLR) attend in March 2025?

ICON plc will attend the Leerink Partners Global Healthcare Conference on March 12 and the Barclays 27th Annual Global Healthcare Conference on March 13, 2025.

Where can investors access ICON plc's (ICLR) conference presentation webcasts?

Live webcasts will be available in the Investor section of ICON's website under the 'Events' tab.

What time is ICON plc's (ICLR) presentation at the Barclays Healthcare Conference?

ICON plc will present at the Barclays 27th Annual Global Healthcare Conference on March 13, 2025, at 8:30 am ET.

ICON PLC

NASDAQ:ICLR

ICLR Rankings

ICLR Latest News

ICLR Stock Data

14.83B
80.04M
0.66%
101.13%
1.95%
Diagnostics & Research
Healthcare
Link
Ireland
Dublin